Mitsubishi Tanabe Pharma Corp - Company Profile
Powered by
All the data and insights you need on Mitsubishi Tanabe Pharma Corp in one report.
- Save hours of research time and resources with
our up-to-date Mitsubishi Tanabe Pharma Corp Strategy Report
- Understand Mitsubishi Tanabe Pharma Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Group Corporation, manufactures and markets pharmaceuticals healthcare products. The company’s strong presence in domestic market, focus on R&D activities and product portfolio are its major strengths, while private ownership restricts ability to raise funds is an area for concern. The company could benefit from promising pipeline products, orphan drug designation, and market potential – CNS therapy. Nevertheless, its performance could be affected by uncertain R&D outcomes, competitive environment, and government regulations.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer